{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T05:56:35Z","timestamp":1781243795359,"version":"3.54.1"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":46,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-026-03084-7","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T15:23:53Z","timestamp":1777303433000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Progress and challenge of hepatitis B virus mucosal vaccines"],"prefix":"10.1186","volume":"23","author":[{"given":"Ji","family":"Renxuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Hongxiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Daru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"issue":"1","key":"3084_CR1","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1186\/s12879-019-4428-y","volume":"19","author":"H Wang","year":"2019","unstructured":"Wang H, Men P, Xiao Y, Gao P, Lv M, Yuan Q, et al. Hepatitis B infection in the general population of china: a systematic review and meta-analysis. BMC Infect Dis. 2019;19(1):811.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"3084_CR2","doi-asserted-by":"publisher","first-page":"e362","DOI":"10.1016\/S1473-3099(24)00307-4","volume":"24","author":"T Burki","year":"2024","unstructured":"Burki T. WHO\u2019s 2024 global hepatitis report. Lancet Infect Dis. 2024;24(6):e362\u20133.","journal-title":"Lancet Infect Dis"},{"issue":"27\u201328","key":"3084_CR3","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.1016\/j.vaccine.2004.03.032","volume":"22","author":"EB Lindblad","year":"2004","unstructured":"Lindblad EB. Aluminium adjuvants\u2013in retrospect and prospect. Vaccine. 2004;22(27\u201328):3658\u201368.","journal-title":"Vaccine"},{"issue":"5","key":"3084_CR4","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/j.0818-9641.2004.01286.x","volume":"82","author":"EB Lindblad","year":"2004","unstructured":"Lindblad EB. Aluminium compounds for use in vaccines. Immunol Cell Biol. 2004;82(5):497\u2013505.","journal-title":"Immunol Cell Biol"},{"issue":"2","key":"3084_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41575-021-00570-x","volume":"19","author":"MH El-Sayed","year":"2022","unstructured":"El-Sayed MH, Feld JJ. Vaccination at the forefront of the fight against hepatitis B and C. Nat Rev Gastroenterol Hepatol. 2022;19(2):87\u20138.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3084_CR6","doi-asserted-by":"crossref","unstructured":"Neutra M R, Kozlowski PA. Mucosal vaccines: the promise and the challenge[J]. Nat Rev Immunol. 2006,;6(2):148-158.","DOI":"10.1038\/nri1777"},{"issue":"1\u20133","key":"3084_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s12026-009-8127-4","volume":"46","author":"Y Thanavala","year":"2010","unstructured":"Thanavala Y, Lugade AA. Oral transgenic plant-based vaccine for hepatitis B. Immunol Res. 2010;46(1\u20133):4\u201311.","journal-title":"Immunol Res"},{"issue":"04","key":"3084_CR8","first-page":"145","volume":"3","author":"H You","year":"2023","unstructured":"You H, Wang FS, Li T, Xu X, Sun Y, Nan Y, et al. Guidelines for the prevention and treatment of chronic hepatitis B (version 2022)[J]. Infect Dis Immun. 2023;3(04):145\u201362.","journal-title":"Infect Dis Immun"},{"key":"3084_CR9","doi-asserted-by":"crossref","unstructured":"Shouval D, Hepatitis B. vaccines. Journal of hepatology, 2003, 39: S70-6.","DOI":"10.1016\/S0168-8278(03)00152-1"},{"issue":"14","key":"3084_CR10","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1001\/jama.1982.03320390074052","volume":"247","author":"S Krugman","year":"1982","unstructured":"Krugman S. The newly licensed hepatitis B vaccine. Characteristics and indications for use. JAMA. 1982;247(14):2012\u20135.","journal-title":"JAMA"},{"issue":"5947","key":"3084_CR11","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/307178a0","volume":"307","author":"WJ McAleer","year":"1984","unstructured":"McAleer WJ, Buynak EB, Maigetter RZ, Wampler DE, Miller WJ, Hilleman MR. Human hepatitis B vaccine from recombinant yeast. Nature. 1984;307(5947):178\u201380.","journal-title":"Nature"},{"issue":"5872","key":"3084_CR12","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/298347a0","volume":"298","author":"P Valenzuela","year":"1982","unstructured":"Valenzuela P, Medina A, Rutter WJ, Ammerer G, Hall BD. Synthesis and assembly of hepatitis B virus surface antigen particles in yeast. Nature. 1982;298(5872):347\u201350.","journal-title":"Nature"},{"issue":"15","key":"3084_CR13","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1016\/j.vaccine.2006.01.007","volume":"24","author":"P Rendi-Wagner","year":"2006","unstructured":"Rendi-Wagner P, Shouval D, Genton B, Lurie Y, Rumke H, Boland G, et al. Comparative immunogenicity of a PreS\/S hepatitis B vaccine in non- and low responders to conventional vaccine. Vaccine. 2006;24(15):2781\u20139.","journal-title":"Vaccine"},{"issue":"16","key":"3084_CR14","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1016\/j.vaccine.2012.02.001","volume":"30","author":"BP Sablan","year":"2012","unstructured":"Sablan BP, Kim DJ, Barzaga NG, Chow WC, Cho M, Ahn SH, et al. Demonstration of safety and enhanced seroprotection against hepatitis B with investigational HBsAg-1018 ISS vaccine compared to a licensed hepatitis B vaccine. Vaccine. 2012;30(16):2689\u201396.","journal-title":"Vaccine"},{"issue":"9","key":"3084_CR15","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/S1473-3099(20)30780-5","volume":"21","author":"T Vesikari","year":"2021","unstructured":"Vesikari T, Langley JM, Segall N, Ward BJ, Cooper C, Poliquin G, et al. Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial. Lancet Infect Dis. 2021;21(9):1271\u201381.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"3084_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-021-00337-0","volume":"6","author":"S Budroni","year":"2021","unstructured":"Budroni S, Buricchi F, Cavallone A, Bourguignon P, Caubet M, Dewar V, et al. Antibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants. NPJ Vaccines. 2021;6(1):78.","journal-title":"NPJ Vaccines"},{"issue":"5","key":"3084_CR17","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1080\/14760584.2021.1908133","volume":"20","author":"GH Lee","year":"2021","unstructured":"Lee GH, Lim SG. CpG-Adjuvanted Hepatitis B Vaccine (HEPLISAV-B\u00ae) Update. Expert Rev Vaccines. 2021;20(5):487\u201395.","journal-title":"Expert Rev Vaccines"},{"issue":"7","key":"3084_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/v14071515","volume":"14","author":"L Romano","year":"2022","unstructured":"Romano L, Zanetti AR. Hepatitis B vaccination: a historical overview with a focus on the Italian achievements. Viruses. 2022;14(7):1515.","journal-title":"Viruses"},{"issue":"8","key":"3084_CR19","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a021428","volume":"5","author":"A Tan","year":"2015","unstructured":"Tan A, Koh S, Bertoletti A. Immune response in hepatitis B virus infection. Cold Spring Harb Perspect Med. 2015;5(8):a021428.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"3084_CR20","doi-asserted-by":"crossref","unstructured":"Brandtzaeg P. Function of mucosa-associated lymphoid tissue in antibody formation. Immunological investigations, 2010, 39 (4\u20135): 303\u2009\u2013\u200955.","DOI":"10.3109\/08820131003680369"},{"key":"3084_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2023.101347","volume":"62","author":"J Yeung","year":"2023","unstructured":"Yeung J, Wang T, Shi PY. Improvement of mucosal immunity by a live-attenuated SARS-CoV-2 nasal vaccine. Curr Opin Virol. 2023;62:101347.","journal-title":"Curr Opin Virol"},{"issue":"1\u20132","key":"3084_CR22","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ijpharm.2017.07.012","volume":"530","author":"B Bernocchi","year":"2017","unstructured":"Bernocchi B, Carpentier R, Betbeder D. Nasal nanovaccines. Int J Pharm. 2017;530(1\u20132):128\u201338.","journal-title":"Int J Pharm"},{"key":"3084_CR23","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3389\/fimmu.2018.00431","volume":"9","author":"B Corth\u00e9sy","year":"2018","unstructured":"Corth\u00e9sy B, Bioley G. Lipid-based particles: versatile delivery systems for mucosal vaccination against infection. Front Immunol. 2018;9:431.","journal-title":"Front Immunol"},{"issue":"1","key":"3084_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.vaccine.2005.07.053","volume":"24","author":"S Saraf","year":"2006","unstructured":"Saraf S, Mishra D, Asthana A, Jain R, Singh S, Jain NK. Lipid microparticles for mucosal immunization against hepatitis B. Vaccine. 2006;24(1):45\u201356.","journal-title":"Vaccine"},{"issue":"3","key":"3084_CR25","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.addr.2004.09.003","volume":"57","author":"W Jiang","year":"2005","unstructured":"Jiang W, Gupta RK, Deshpande MC, Schwendeman SP. Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens. Adv Drug Deliv Rev. 2005;57(3):391\u2013410.","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"3084_CR26","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.addr.2004.09.004","volume":"57","author":"HO Alpar","year":"2005","unstructured":"Alpar HO, Somavarapu S, Atuah KN, Bramwell VW. Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery. Adv Drug Deliv Rev. 2005;57(3):411\u201330.","journal-title":"Adv Drug Deliv Rev"},{"issue":"19","key":"3084_CR27","doi-asserted-by":"publisher","first-page":"4201","DOI":"10.1016\/j.vaccine.2006.01.011","volume":"24","author":"KS Jaganathan","year":"2006","unstructured":"Jaganathan KS, Vyas SP. Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally. Vaccine. 2006;24(19):4201\u201311.","journal-title":"Vaccine"},{"key":"3084_CR28","first-page":"9","volume":"11","author":"K Shiraishi","year":"2023","unstructured":"Shiraishi K, Yoshida O, Imai Y, Akbar SMF, Sanada T, Kohara M, et al. Intranasal HBsAg\/HBcAg-Containing vaccine induces neutralizing Anti-HBs production in hepatitis B vaccine Non-Responders. Vaccines (Basel). 2023;11:9.","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"3084_CR29","doi-asserted-by":"publisher","first-page":"8325","DOI":"10.1080\/21655979.2021.1985816","volume":"12","author":"E Ivanova","year":"2021","unstructured":"Ivanova E. Yeasts in nanotechnology-enabled oral vaccine and gene delivery. Bioengineered. 2021;12(1):8325\u201335.","journal-title":"Bioengineered"},{"issue":"4","key":"3084_CR30","doi-asserted-by":"publisher","first-page":"347","DOI":"10.2174\/156720109789000537","volume":"6","author":"P Simerska","year":"2009","unstructured":"Simerska P, Moyle PM, Olive C, Toth I. Oral vaccine delivery-new strategies and technologies. Curr Drug Deliv. 2009;6(4):347\u201358.","journal-title":"Curr Drug Deliv"},{"issue":"7","key":"3084_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11071232","volume":"11","author":"KWY Kwong","year":"2023","unstructured":"Kwong KWY, Xin Y, Lai NCY, Sung JCC, Wu KC, Hamied YK, et al. Oral vaccines: a better future of immunization. Vaccines. 2023;11(7):1232.","journal-title":"Vaccines"},{"issue":"2","key":"3084_CR32","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ymeth.2005.09.013","volume":"38","author":"SJ Streatfield","year":"2006","unstructured":"Streatfield SJ. Mucosal immunization using recombinant plant-based oral vaccines. Methods. 2006;38(2):150\u20137.","journal-title":"Methods"},{"issue":"3","key":"3084_CR33","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.1440-1711.2005.01335.x","volume":"83","author":"SJ Streatfield","year":"2005","unstructured":"Streatfield SJ. Oral hepatitis B vaccine candidates produced and delivered in plant material. Immunol Cell Biol. 2005;83(3):257\u201362.","journal-title":"Immunol Cell Biol"},{"issue":"5","key":"3084_CR34","doi-asserted-by":"publisher","first-page":"996","DOI":"10.3748\/wjg.v9.i5.996","volume":"9","author":"Y Gao","year":"2003","unstructured":"Gao Y, Ma Y, Li M, Cheng T, Li SW, Zhang J, et al. Oral immunization of animals with Transgenic Cherry Tomatillo expressing HBsAg. World J Gastroenterol. 2003;9(5):996\u20131002.","journal-title":"World J Gastroenterol"},{"issue":"11","key":"3084_CR35","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/81153","volume":"18","author":"LJ Richter","year":"2000","unstructured":"Richter LJ, Thanavala Y, Arntzen CJ, Mason HS. Production of hepatitis B surface antigen in transgenic plants for oral immunization. Nat Biotechnol. 2000;18(11):1167\u201371.","journal-title":"Nat Biotechnol"},{"issue":"9","key":"3084_CR36","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.1073\/pnas.0409899102","volume":"102","author":"Y Thanavala","year":"2005","unstructured":"Thanavala Y, Mahoney M, Pal S, Scott A, Richte L, Natarajan N, et al. Immunogenicity in humans of an edible vaccine for hepatitis B. Proc Natl Acad Sci USA. 2005;102(9):3378\u201382.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"3084_CR37","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1007\/s00425-005-1556-y","volume":"222","author":"GB Kumar","year":"2005","unstructured":"Kumar GB, Ganapathi TR, Revathi CJ, Srinivas L, Bapat VA. Expression of hepatitis B surface antigen in transgenic banana plants. Planta. 2005;222(3):484\u201393.","journal-title":"Planta"},{"issue":"7\u20138","key":"3084_CR38","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/S0264-410X(02)00605-9","volume":"21","author":"SJ Streatfield","year":"2003","unstructured":"Streatfield SJ, Lane JR, Brooks CA, Barker DK, Poage ML, Mayor JM, et al. Corn as a production system for human and animal vaccines. Vaccine. 2003;21(7\u20138):812\u20135.","journal-title":"Vaccine"},{"issue":"24","key":"3084_CR39","doi-asserted-by":"publisher","first-page":"11745","DOI":"10.1073\/pnas.89.24.11745","volume":"89","author":"HS Mason","year":"1992","unstructured":"Mason HS, Lam DM, Arntzen CJ. Expression of hepatitis B surface antigen in transgenic plants. Proc Natl Acad Sci USA. 1992;89(24):11745\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"3084_CR40","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1016\/j.apsb.2021.12.021","volume":"12","author":"C Feng","year":"2022","unstructured":"Feng C, Li Y, Ferdows BE, Patel DN, Ouyang J, Tang Z, et al. Emerging vaccine nanotechnology: from defense against infection to sniping cancer. Acta Pharm Sin B. 2022;12(5):2206\u201323.","journal-title":"Acta Pharm Sin B"},{"key":"3084_CR41","doi-asserted-by":"crossref","unstructured":"Zafar A, Arshad R, Ur Rehman A, Ahmed N, Akhtar H. Recent developments in oral delivery of vaccines using nanocarriers. Vaccines (Basel). 2023;11(2):490.","DOI":"10.3390\/vaccines11020490"},{"key":"3084_CR42","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.addr.2016.06.018","volume":"107","author":"B Tyler","year":"2016","unstructured":"Tyler B, Gullotti D, Mangraviti A, Utsuki T, Brem H. Polylactic acid (PLA) controlled delivery carriers for biomedical applications. Adv Drug Deliv Rev. 2016;107:163\u201375.","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"3084_CR43","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1586\/erm.09.15","volume":"9","author":"JM L\u00fc","year":"2009","unstructured":"L\u00fc JM, Wang X, Marin-Muller C, Wang H, Lin PH, Yao Q, et al. Current advances in research and clinical applications of PLGA-based nanotechnology. Expert Rev Mol Diagn. 2009;9(4):325\u201341.","journal-title":"Expert Rev Mol Diagn"},{"issue":"3","key":"3084_CR44","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1046\/j.1365-2567.2002.01448.x","volume":"106","author":"VW Bramwell","year":"2002","unstructured":"Bramwell VW, Eyles JE, Somavarapu S, Alpar HO. Liposome\/DNA complexes coated with biodegradable PLA improve immune responses to plasmid encoding hepatitis B surface antigen. Immunology. 2002;106(3):412\u20138.","journal-title":"Immunology"},{"issue":"6","key":"3084_CR45","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1021\/mp400597z","volume":"11","author":"X Chen","year":"2014","unstructured":"Chen X, Liu Y, Wang L, Liu Y, Zhang W, Fan B, et al. Enhanced humoral and cell-mediated immune responses generated by cationic polymer-coated PLA microspheres with adsorbed HBsAg. Mol Pharm. 2014;11(6):1772\u201384.","journal-title":"Mol Pharm"},{"key":"3084_CR46","doi-asserted-by":"crossref","unstructured":"Jain AK, Goyal AK, Mishra N, Vaidya B, Mangal S, Vyas SP. PEG-PLA-PEG block copolymeric nanoparticles for oral immunization against hepatitis B. Int J Pharm, 2010, 387 (1\u20132): 253\u2009\u2013\u200962.","DOI":"10.1016\/j.ijpharm.2009.12.013"},{"issue":"1","key":"3084_CR47","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3109\/10611861003733946","volume":"19","author":"N Mishra","year":"2011","unstructured":"Mishra N, Tiwari S, Vaidya B, Agrawal GP, Vyas SP. Lectin anchored PLGA nanoparticles for oral mucosal immunization against hepatitis B. J Drug Target. 2011;19(1):67\u201378.","journal-title":"J Drug Target"},{"issue":"27","key":"3084_CR48","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1016\/j.vaccine.2016.04.084","volume":"34","author":"AK Dinda","year":"2016","unstructured":"Dinda AK, Bhat M, Srivastava S, Kottarath SK, Prashant CK. Novel nanocarrier for oral hepatitis B vaccine. Vaccine. 2016;34(27):3076\u201381.","journal-title":"Vaccine"},{"issue":"12","key":"3084_CR49","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1002\/1520-6017(200012)89:12<1550::AID-JPS5>3.0.CO;2-Z","volume":"89","author":"M Machluf","year":"2000","unstructured":"Machluf M, Apte RN, Regev O, Cohen S. Enhancing the immunogenicity of liposomal hepatitis B surface antigen (HBsAg) by controlling its delivery from polymeric microspheres. J Pharm Sci. 2000;89(12):1550\u20137.","journal-title":"J Pharm Sci"},{"issue":"11","key":"3084_CR50","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1002\/jbm.a.37198","volume":"109","author":"X Wu","year":"2021","unstructured":"Wu X, Farooq MA, Li T, Geng T, Kutoka PT, Wang B. Cationic chitosan-modified silica nanoparticles for oral delivery of protein vaccine. J Biomed Mater Res A. 2021;109(11):2111\u20139.","journal-title":"J Biomed Mater Res A"},{"issue":"2","key":"3084_CR51","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.biomaterials.2010.08.107","volume":"32","author":"A Li","year":"2011","unstructured":"Li A, Qin L, Wang W, Zhu R, Yu Y, Liu H, et al. The use of layered double hydroxides as DNA vaccine delivery vector for enhancement of anti-melanoma immune response. Biomaterials. 2011;32(2):469\u201377.","journal-title":"Biomaterials"},{"issue":"4","key":"3084_CR52","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.biomaterials.2009.09.095","volume":"31","author":"A Li","year":"2010","unstructured":"Li A, Qin L, Zhu D, Zhu R, Sun J, Wang S. Signalling pathways involved in the activation of dendritic cells by layered double hydroxide nanoparticles. Biomaterials. 2010;31(4):748\u201356.","journal-title":"Biomaterials"},{"issue":"1","key":"3084_CR53","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.biomaterials.2013.09.060","volume":"35","author":"J Wang","year":"2014","unstructured":"Wang J, Zhu R, Gao B, Wu B, Li K, Sun X, et al. The enhanced immune response of hepatitis B virus DNA vaccine using SiO2@LDH nanoparticles as an adjuvant. Biomaterials. 2014;35(1):466\u201378.","journal-title":"Biomaterials"},{"issue":"8","key":"3084_CR54","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1016\/j.nano.2016.06.003","volume":"12","author":"K Scaramuzzi","year":"2016","unstructured":"Scaramuzzi K, Tanaka GD, Neto FM, Garcia PR, Gabrili JJ, Oliveira DC, et al. Nanostructured SBA-15 silica: an effective protective vehicle to oral hepatitis B vaccine immunization. Nanomedicine-Nanotechnol Biol Med. 2016;12(8):2241\u201350.","journal-title":"Nanomedicine-Nanotechnol Biol Med"},{"key":"3084_CR55","doi-asserted-by":"crossref","unstructured":"Krylova SV, Feng D. The machinery of exosomes: Biogenesis, Release, and uptake. Int J Mol Sci. 2023;24(2):1337.","DOI":"10.3390\/ijms24021337"},{"key":"3084_CR56","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.jconrel.2015.07.030","volume":"219","author":"EV Batrakova","year":"2015","unstructured":"Batrakova EV, Kim MS. Using exosomes, naturally-equipped nanocarriers, for drug delivery. J Controlled Release: Official J Controlled Release Soc. 2015;219:396\u2013405.","journal-title":"J Controlled Release: Official J Controlled Release Soc"},{"issue":"1\u20132","key":"3084_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11010-019-03545-4","volume":"459","author":"A Familtseva","year":"2019","unstructured":"Familtseva A, Jeremic N, Tyagi SC. Exosomes: cell-created drug delivery systems. Mol Cell Biochem. 2019;459(1\u20132):1\u20136.","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"3084_CR58","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2024.2345940","volume":"20","author":"Z Dai","year":"2024","unstructured":"Dai Z, Cai R, Zeng H, Zhu H, Dou Y, Sun S. Exosome may be the next generation of promising cell-free vaccines. Hum Vaccin Immunother. 2024;20(1):2345940.","journal-title":"Hum Vaccin Immunother"},{"key":"3084_CR59","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.jconrel.2022.05.027","volume":"347","author":"I Kimiz-Gebologlu","year":"2022","unstructured":"Kimiz-Gebologlu I, Oncel SS. Exosomes: large-scale production, isolation, drug loading efficiency, and biodistribution and uptake. J Control Release. 2022;347:533\u201343.","journal-title":"J Control Release"},{"key":"3084_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpb.2018.09.029","volume":"133","author":"S Jesus","year":"2018","unstructured":"Jesus S, Soares E, Cruz MT, Borges O. Exosomes as adjuvants for the recombinant hepatitis B antigen: first report. Eur J Pharm Biopharm. 2018;133:1\u201311.","journal-title":"Eur J Pharm Biopharm"},{"issue":"5","key":"3084_CR61","doi-asserted-by":"publisher","first-page":"C865","DOI":"10.1152\/ajpcell.00029.2022","volume":"322","author":"A Ngu","year":"2022","unstructured":"Ngu A, Wang S, Wang H, Khanam A, Zempleni J. Milk exosomes in nutrition and drug delivery. Am J Physiol Cell Physiol. 2022;322(5):C865\u201374.","journal-title":"Am J Physiol Cell Physiol"},{"key":"3084_CR62","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/978-1-4939-9769-5_4","volume":"2054","author":"X Wu","year":"2019","unstructured":"Wu X, Showiheen SAA, Sun AR, Crawford R, Xiao Y, Mao X, et al. Exosomes extraction and identification. Methods in molecular biology (Clifton, NJ). 2019;2054:81\u201391.","journal-title":"Methods in molecular biology (Clifton, N.J.)"},{"key":"3084_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11030673","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Wang M, Han C, Wen Z, Meng X, Qi D, et al. Intraduodenal delivery of exosome-loaded SARS-CoV-2 RBD mRNA induces a neutralizing antibody response in mice. Vaccines (Basel). 2023. https:\/\/doi.org\/10.3390\/vaccines11030673.","journal-title":"Vaccines (Basel)"},{"key":"3084_CR64","doi-asserted-by":"crossref","unstructured":"Potchen NB, Johnson AMF, Hager K, Graham J, Van P, Lyn-Kew K et al. Oral tolerance to systemic vaccination remains intact without ROR\u03b3t expression in regulatory T cells. Iscience. 2023;26(12):108504.","DOI":"10.1016\/j.isci.2023.108504"},{"key":"3084_CR65","doi-asserted-by":"crossref","unstructured":"Pandey B, Wang Z, Jimenez A, Bhatia E, Jain R, Beach A, et al. A dual-adjuvanted parenteral-intranasal subunit nanovaccine generates robust systemic and mucosal immunity against SARS-CoV-2 in mice. Advanced Science (Weinh). 2024;11(45):e2402792.","DOI":"10.1002\/advs.202402792"},{"key":"3084_CR66","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ejpb.2015.04.004","volume":"93","author":"HP Patil","year":"2015","unstructured":"Patil HP, Murugappan S, de Vries-Idema J, Meijerhof T, de Haan A, Frijlink HW, et al. Comparison of adjuvants for a spray freeze-dried whole inactivated virus influenza vaccine for pulmonary administration. Eur J Pharm Biopharm. 2015;93:231\u201341.","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"3084_CR67","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1046\/j.1365-2567.2003.01570.x","volume":"108","author":"AD Eaton","year":"2003","unstructured":"Eaton AD, Xu D, Garside P. Administration of exogenous interleukin-18 and interleukin-12 prevents the induction of oral tolerance. Immunology. 2003;108(2):196\u2013203.","journal-title":"Immunology"},{"key":"3084_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.120167","volume":"594","author":"Z Jia","year":"2021","unstructured":"Jia Z, Wignall A, Prestidge C, Thierry B. An ex vivo investigation of the intestinal uptake and translocation of nanoparticles targeted to Peyer\u2019s patches microfold cells. Int J Pharm. 2021;594:120167.","journal-title":"Int J Pharm"},{"issue":"9","key":"3084_CR69","doi-asserted-by":"publisher","first-page":"4695","DOI":"10.1021\/acs.analchem.4c05801","volume":"97","author":"L Zhu","year":"2025","unstructured":"Zhu L, Du J, Cheng X, Hu R, Li X, Chen X, et al. Microfluidic innovations for enhanced extracellular vesicle isolation and analysis: a comprehensive review. Anal Chem. 2025;97(9):4695\u2013705.","journal-title":"Anal Chem"},{"issue":"7","key":"3084_CR70","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13622","volume":"57","author":"XTT Dang","year":"2024","unstructured":"Dang XTT, Phung CD, Lim CMH, Jayasinghe MK, Ang J, Tran T, et al. Dendritic cell-targeted delivery of antigens using extracellular vesicles for anti-cancer immunotherapy. Cell Prolif. 2024;57(7):e13622.","journal-title":"Cell Prolif"},{"key":"3084_CR71","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.jconrel.2024.07.056","volume":"373","author":"J Zheng","year":"2024","unstructured":"Zheng J, Wang M, Pang L, Wang S, Kong Y, Zhu X, et al. Identification of a novel DEC-205 binding peptide to develop dendritic cell-targeting nanovaccine for cancer immunotherapy. J Control Release. 2024;373:568\u201382.","journal-title":"J Control Release"},{"issue":"4","key":"3084_CR72","doi-asserted-by":"publisher","first-page":"e615","DOI":"10.1093\/infdis\/jiae613","volume":"231","author":"C Olal","year":"2025","unstructured":"Olal C, Bodmer BS, Rottstegge M, Escudero-P\u00e9rez B, Port JR, Bencsik A, et al. Antibody-based antigen delivery to dendritic cells as a vaccination strategy against Ebola virus disease. J Infect Dis. 2025;231(4):e615\u201325.","journal-title":"J Infect Dis"},{"issue":"11","key":"3084_CR73","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1007\/s00216-025-05824-0","volume":"417","author":"C Mata","year":"2025","unstructured":"Mata C, Pimentel JM, Huang K, Stamatikos A, Marcus RK. Isolation of bovine milk-derived extracellular vesicles via a capillary-channeled polymer (C-CP) fiber stationary phase. Anal Bioanal Chem. 2025;417(11):2345\u201359.","journal-title":"Anal Bioanal Chem"},{"issue":"4","key":"3084_CR74","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1021\/acsabm.4c01821","volume":"8","author":"H Lee","year":"2025","unstructured":"Lee H, Lee J, Ko M, Lee KN, Kim Y, Seo B, et al. Advanced exosome isolation through electrophoretic oscillation-assisted tangent-flow ultrafiltration with a PVDF-fiber-coated SiN x nanofilter. ACS Appl Bio Mater. 2025;8(4):2965\u201376.","journal-title":"ACS Appl Bio Mater"},{"issue":"11","key":"3084_CR75","doi-asserted-by":"publisher","first-page":"e70009","DOI":"10.1002\/jex2.70009","volume":"3","author":"L Lu","year":"2024","unstructured":"Lu L, Han C, Wang M, Du H, Chen N, Gao M, et al. Assessment of bovine milk exosome Preparation and lyophilized powder stability. J Extracell Biology. 2024;3(11):e70009.","journal-title":"J Extracell Biology"},{"key":"3084_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.vesic.2023.100029","volume":"2","author":"K Cheng","year":"2023","unstructured":"Cheng K, Kalluri R. Guidelines for clinical translation and commercialization of extracellular vesicles and exosomes based therapeutics. Extracellular Vesicle. 2023;2:100029.","journal-title":"Extracellular Vesicle"},{"key":"3084_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2025.123472","author":"R Tandon","year":"2025","unstructured":"Tandon R, Srivastava N. Unravelling exosome paradigm: therapeutic, diagnostic and theranostics application and regulatory consideration. Life Sci. 2025. https:\/\/doi.org\/10.1016\/j.lfs.2025.123472.","journal-title":"Life Sci"},{"key":"3084_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-66622-x","author":"Y Yue","year":"2025","unstructured":"Yue Y, Xin Q, Zhu Y, Zhu D, Zhang B, Yan X, et al. Probiotic-based oral vaccine mucosal delivery system enabling genetically encoded dual-antigen arrays. Nat Commun. 2025. https:\/\/doi.org\/10.1038\/s41467-025-66622-x.","journal-title":"Nat Commun"},{"key":"3084_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.celbio.2025.100180","author":"S Qin","year":"2025","unstructured":"Qin S, Zheng Q, Zhang Y, Jin X, Jiao X, Niu Z. A precision-engineered dendritic cell-targeted mRNA nanovaccine for enhanced antiviral immunity. Cell Biomater. 2025. https:\/\/doi.org\/10.1016\/j.celbio.2025.100180.","journal-title":"Cell Biomater"},{"key":"3084_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2025.102721","volume":"62","author":"L Huang","year":"2025","unstructured":"Huang L, Sun X, Song T, Long J, Chen X, Dong R, et al. The swarmable magnetic-driven nanorobots for facilitating trans-intestinal mucosal delivery of oral vaccines to enhance mucosal and systemic immune responses. Nano Today. 2025;62:102721.","journal-title":"Nano Today"},{"issue":"43","key":"3084_CR81","doi-asserted-by":"publisher","first-page":"1904828","DOI":"10.1002\/adfm.201904828","volume":"29","author":"YB Miao","year":"2019","unstructured":"Miao YB, Pan WY, Chen KH, Wei HJ, Mi FL, Lu MY, et al. Engineering a nanoscale Al-MOF\u2010armored antigen carried by a Trojan horse\u2010like platform for oral vaccination to induce potent and long\u2010lasting immunity. Adv Funct Mater. 2019;29(43):1904828.","journal-title":"Adv Funct Mater"},{"issue":"1","key":"3084_CR82","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41577-024-01077-7","volume":"25","author":"V Cerovic","year":"2025","unstructured":"Cerovic V, Pabst O, Mowat AMI. The renaissance of oral tolerance: merging tradition and new insights. Nat Rev Immunol. 2025;25(1):42\u201356.","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"3084_CR83","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1039\/D4BM00026A","volume":"12","author":"S Mi","year":"2024","unstructured":"Mi S, Li W, Wen Y, Yang C, Liu S, Li J, et al. Layer-by-layer nanoparticle encapsulating all-trans retinoic acid and CpG as a mucosal adjuvant targeting colorectal cancer. Biomater Sci. 2024;12(9):2292\u2013301.","journal-title":"Biomater Sci"},{"key":"3084_CR84","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00442","volume":"11","author":"AS De Groot","year":"2020","unstructured":"De Groot AS, Moise L, Terry F, Gutierrez AH, Hindocha P, Richard G, et al. Better epitope discovery, precision immune engineering, and accelerated vaccine design using immunoinformatics tools. Front Immunol. 2020;11:442.","journal-title":"Front Immunol"},{"issue":"18","key":"3084_CR85","doi-asserted-by":"publisher","first-page":"3550","DOI":"10.1021\/acs.accounts.1c00411","volume":"54","author":"Y Wang","year":"2021","unstructured":"Wang Y, Wang P, Qin J. Microfluidic organs-on-a-chip for modeling human infectious diseases. Acc Chem Res. 2021;54(18):3550\u201362.","journal-title":"Acc Chem Res"},{"issue":"7","key":"3084_CR86","doi-asserted-by":"publisher","first-page":"100886","DOI":"10.1016\/j.landig.2025.100886","volume":"7","author":"A Hadid","year":"2025","unstructured":"Hadid A, McDonald EG, Ding Q, Phillipp C, Trottier A, Dixon PC, et al. Development of machine learning prediction models for systemic inflammatory response following controlled exposure to a live attenuated influenza vaccine in healthy adults using multimodal wearable biosensors in Canada: a single-centre, prospective controlled trial. Lancet Digit Health. 2025;7(7):100886.","journal-title":"Lancet Digit Health"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-026-03084-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-026-03084-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-026-03084-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T04:56:08Z","timestamp":1781240168000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12985-026-03084-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3084"],"URL":"https:\/\/doi.org\/10.1186\/s12985-026-03084-7","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"9 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree to the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"151"}}